Medco-Express Scripts deal analysis
In closing its investigation of the Express Scripts-Medco merger, the FTC was following its own long history of taking a more tolerant approach than the Department of Justice’s Antitrust Division toward...To view the full article, register now.
Already a subscriber? Click here to view full article